Browsing Tag
chronic kidney disease
24 posts
XORTX surges after $3M Vectus Biosystems deal adds promising anti-fibrotic kidney drug to pipeline
Find out how XORTX’s $3 million Vectus Biosystems acquisition could reshape the renal fibrosis market and accelerate its transformation into a leading kidney disease innovator.
ProKidney (NASDAQ: PROK) stock surges over 22% after Phase 2 REGEN-007 trial shows strong kidney function stabilization
Find out why ProKidney stock soared 22% after new Phase 2 data on rilparencel in chronic kidney disease patients. Analysts see potential FDA fast-track.
BioCity’s SC0062 secures second breakthrough therapy designation in China for diabetic kidney disease
BioCity Biopharma’s ETA-selective SC0062 earns second Breakthrough Therapy Designation in China for diabetic kidney disease, reinforcing its CKD potential.
Unicycive (NASDAQ: UNCY) hit by FDA manufacturing concerns ahead of oxylanthanum carbonate decision
Unicycive’s NDA for oxylanthanum carbonate faces FDA manufacturing concerns. Key decision expected June 28. Read the stock outlook and next steps.
Alkem Laboratories’ latest drug launch promises relief for millions of diabetics in India
Alkem Laboratories Limited has launched its generic version of empagliflozin and its combinations in India under the brand…
Fresenius Medical Care sells laboratory assets to Quest Diagnostics in strategic portfolio shift
Fresenius Medical Care has announced the sale of select laboratory assets to Quest Diagnostics as part of a…
Zydus and CSIR-CDRI launch collaborative research for new CKD-induced osteoporosis treatment
Zydus Lifesciences Ltd and CSIR-Central Drug Research Institute (CDRI) have joined forces to develop an innovative drug targeting…
Novo Nordisk faces setback as CLARION-CKD trial fails, leading to significant financial impairment
Novo Nordisk, a global leader in pharmaceuticals, has announced a major setback as its CLARION-CKD phase 3 trial…
FDA approves Akebia Therapeutics’ Vafseo for anemia in dialysis patients
In a significant development for the treatment of anemia related to chronic kidney disease (CKD) in dialysis patients,…
Bayer and Sun Pharma join forces for new brand of Finerenone in India
In a significant development for the Indian healthcare sector, Sun Pharmaceutical Industries Limited and Bayer have announced a…